Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas

Purpose To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands. Methods Twenty cases of pleomorphic adenomas and 20 cases of a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European archives of oto-rhino-laryngology 2018-12, Vol.275 (12), p.3075-3082
Hauptverfasser: Souza Freitas, Valéria, dos Santos, Jean Nunes, de Andrade Santos, Pedro Paulo, Nonaka, Cassiano Francisco Weege, Pereira Pinto, Leão, de Souza, Lélia Batista
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3082
container_issue 12
container_start_page 3075
container_title European archives of oto-rhino-laryngology
container_volume 275
creator Souza Freitas, Valéria
dos Santos, Jean Nunes
de Andrade Santos, Pedro Paulo
Nonaka, Cassiano Francisco Weege
Pereira Pinto, Leão
de Souza, Lélia Batista
description Purpose To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands. Methods Twenty cases of pleomorphic adenomas and 20 cases of adenoid cystic carcinomas were evaluated for the immunohistochemical expression of matrix metalloproteinases-2, -7, -9, and -26 and tissue inhibitors-1 and -2 in tumor parenchyma. Results Most pleomorphic adenomas and adenoid cystic carcinomas showed high expression of matrix metalloproteinases and tissue inhibitors, predominantly located in the tumor cells. There was no statistically significant difference in the expression of the metalloproteinases-2 ( p  = 0.359), -7 ( p  = 0.081), and -26 ( p  = 0 553), as well as the tissue inhibitors-1 ( p  = 0.657), and -2 ( p  = 0.248) between the parenchyma of the studied tumors. Only matrix metalloproteinase-9 showed a significant difference in expression between the two tumors, with adenoid cystic carcinoma showing a more intense staining for this gelatinase ( p  = 0.041). Conclusions The expression of the studied metalloproteinases suggests the involvement of these enzymes in the tissue remodeling process in pleomorphic adenomas and adenoid cystic carcinomas, but only MMP-9, significantly expressed in the adenoid cystic carcinomas, appears to be involved in the process of invasiveness and more aggressive behavior of these tumors. Additionally, results point that TIMPs-1 and -2 may have more complex functions besides metalloproteinase inhibition, which may be related to the pathogenesis and biological behavior of salivary gland tumors.
doi_str_mv 10.1007/s00405-018-5176-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2126907951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2126907951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-fced90214f4737351c5bb0981bd74630edbfdd8efc64ff696c80005036fcec303</originalsourceid><addsrcrecordid>eNp9kc1u1TAUhC0EoreFB2CDvGylGuzYsZMlqkqp1AoWZW05_qGukjj4JFL7XjwgTu6FVdWFZVsz80nnDEIfGP3EKFWfgVJBa0JZQ2qmJKGv0I4JLohQlXyNdrTligih1BE6BniglNai5W_REadcMtWoHfpz-ThlDxDTiFPAg5lzfMSDn03fpymn2cfRgAd8env7A0h1jokqpz3HZnSYVPJse8wRYPE4jvexi3PKsMGeodxdrxh2SJ-VBJ56n4aUp_tosXF-TIOBTd8-0WH7BHPRrMk2buo79CaYHvz7w32Cfn69vLv4Rm6-X11ffLkhlgsxk2C9a2nFRBCKK14zW3cdbRvWOSUkp951wbnGBytFCLKVtllXVHZTkrbs6ASd7rllhN-Lh1kPEazvezP6tICuWCVbqtqaFSvbW21OANkHPeU4mPykGdVrWXpfli5l6bUsveI_HvBLN3j3P_GvnWKo9gYo0vjLZ_2QljyWkV-g_gVctZ-7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126907951</pqid></control><display><type>article</type><title>Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Souza Freitas, Valéria ; dos Santos, Jean Nunes ; de Andrade Santos, Pedro Paulo ; Nonaka, Cassiano Francisco Weege ; Pereira Pinto, Leão ; de Souza, Lélia Batista</creator><creatorcontrib>Souza Freitas, Valéria ; dos Santos, Jean Nunes ; de Andrade Santos, Pedro Paulo ; Nonaka, Cassiano Francisco Weege ; Pereira Pinto, Leão ; de Souza, Lélia Batista</creatorcontrib><description>Purpose To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands. Methods Twenty cases of pleomorphic adenomas and 20 cases of adenoid cystic carcinomas were evaluated for the immunohistochemical expression of matrix metalloproteinases-2, -7, -9, and -26 and tissue inhibitors-1 and -2 in tumor parenchyma. Results Most pleomorphic adenomas and adenoid cystic carcinomas showed high expression of matrix metalloproteinases and tissue inhibitors, predominantly located in the tumor cells. There was no statistically significant difference in the expression of the metalloproteinases-2 ( p  = 0.359), -7 ( p  = 0.081), and -26 ( p  = 0 553), as well as the tissue inhibitors-1 ( p  = 0.657), and -2 ( p  = 0.248) between the parenchyma of the studied tumors. Only matrix metalloproteinase-9 showed a significant difference in expression between the two tumors, with adenoid cystic carcinoma showing a more intense staining for this gelatinase ( p  = 0.041). Conclusions The expression of the studied metalloproteinases suggests the involvement of these enzymes in the tissue remodeling process in pleomorphic adenomas and adenoid cystic carcinomas, but only MMP-9, significantly expressed in the adenoid cystic carcinomas, appears to be involved in the process of invasiveness and more aggressive behavior of these tumors. Additionally, results point that TIMPs-1 and -2 may have more complex functions besides metalloproteinase inhibition, which may be related to the pathogenesis and biological behavior of salivary gland tumors.</description><identifier>ISSN: 0937-4477</identifier><identifier>EISSN: 1434-4726</identifier><identifier>DOI: 10.1007/s00405-018-5176-0</identifier><identifier>PMID: 30361787</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adenoma, Pleomorphic - metabolism ; Adenoma, Pleomorphic - pathology ; Carcinoma, Adenoid Cystic - metabolism ; Carcinoma, Adenoid Cystic - pathology ; Head &amp; Neck ; Head and Neck Surgery ; Humans ; Immunohistochemistry ; Matrix Metalloproteinases - metabolism ; Medicine ; Medicine &amp; Public Health ; Neurosurgery ; Otorhinolaryngology ; Salivary Gland Neoplasms - metabolism ; Salivary Gland Neoplasms - pathology ; Salivary Glands, Minor - metabolism ; Salivary Glands, Minor - pathology ; Tissue Inhibitor of Metalloproteinase-1 - metabolism ; Tissue Inhibitor of Metalloproteinase-2 - metabolism</subject><ispartof>European archives of oto-rhino-laryngology, 2018-12, Vol.275 (12), p.3075-3082</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-fced90214f4737351c5bb0981bd74630edbfdd8efc64ff696c80005036fcec303</citedby><cites>FETCH-LOGICAL-c344t-fced90214f4737351c5bb0981bd74630edbfdd8efc64ff696c80005036fcec303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00405-018-5176-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00405-018-5176-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30361787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Souza Freitas, Valéria</creatorcontrib><creatorcontrib>dos Santos, Jean Nunes</creatorcontrib><creatorcontrib>de Andrade Santos, Pedro Paulo</creatorcontrib><creatorcontrib>Nonaka, Cassiano Francisco Weege</creatorcontrib><creatorcontrib>Pereira Pinto, Leão</creatorcontrib><creatorcontrib>de Souza, Lélia Batista</creatorcontrib><title>Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas</title><title>European archives of oto-rhino-laryngology</title><addtitle>Eur Arch Otorhinolaryngol</addtitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><description>Purpose To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands. Methods Twenty cases of pleomorphic adenomas and 20 cases of adenoid cystic carcinomas were evaluated for the immunohistochemical expression of matrix metalloproteinases-2, -7, -9, and -26 and tissue inhibitors-1 and -2 in tumor parenchyma. Results Most pleomorphic adenomas and adenoid cystic carcinomas showed high expression of matrix metalloproteinases and tissue inhibitors, predominantly located in the tumor cells. There was no statistically significant difference in the expression of the metalloproteinases-2 ( p  = 0.359), -7 ( p  = 0.081), and -26 ( p  = 0 553), as well as the tissue inhibitors-1 ( p  = 0.657), and -2 ( p  = 0.248) between the parenchyma of the studied tumors. Only matrix metalloproteinase-9 showed a significant difference in expression between the two tumors, with adenoid cystic carcinoma showing a more intense staining for this gelatinase ( p  = 0.041). Conclusions The expression of the studied metalloproteinases suggests the involvement of these enzymes in the tissue remodeling process in pleomorphic adenomas and adenoid cystic carcinomas, but only MMP-9, significantly expressed in the adenoid cystic carcinomas, appears to be involved in the process of invasiveness and more aggressive behavior of these tumors. Additionally, results point that TIMPs-1 and -2 may have more complex functions besides metalloproteinase inhibition, which may be related to the pathogenesis and biological behavior of salivary gland tumors.</description><subject>Adenoma, Pleomorphic - metabolism</subject><subject>Adenoma, Pleomorphic - pathology</subject><subject>Carcinoma, Adenoid Cystic - metabolism</subject><subject>Carcinoma, Adenoid Cystic - pathology</subject><subject>Head &amp; Neck</subject><subject>Head and Neck Surgery</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosurgery</subject><subject>Otorhinolaryngology</subject><subject>Salivary Gland Neoplasms - metabolism</subject><subject>Salivary Gland Neoplasms - pathology</subject><subject>Salivary Glands, Minor - metabolism</subject><subject>Salivary Glands, Minor - pathology</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - metabolism</subject><issn>0937-4477</issn><issn>1434-4726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAUhC0EoreFB2CDvGylGuzYsZMlqkqp1AoWZW05_qGukjj4JFL7XjwgTu6FVdWFZVsz80nnDEIfGP3EKFWfgVJBa0JZQ2qmJKGv0I4JLohQlXyNdrTligih1BE6BniglNai5W_REadcMtWoHfpz-ThlDxDTiFPAg5lzfMSDn03fpymn2cfRgAd8env7A0h1jokqpz3HZnSYVPJse8wRYPE4jvexi3PKsMGeodxdrxh2SJ-VBJ56n4aUp_tosXF-TIOBTd8-0WH7BHPRrMk2buo79CaYHvz7w32Cfn69vLv4Rm6-X11ffLkhlgsxk2C9a2nFRBCKK14zW3cdbRvWOSUkp951wbnGBytFCLKVtllXVHZTkrbs6ASd7rllhN-Lh1kPEazvezP6tICuWCVbqtqaFSvbW21OANkHPeU4mPykGdVrWXpfli5l6bUsveI_HvBLN3j3P_GvnWKo9gYo0vjLZ_2QljyWkV-g_gVctZ-7</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Souza Freitas, Valéria</creator><creator>dos Santos, Jean Nunes</creator><creator>de Andrade Santos, Pedro Paulo</creator><creator>Nonaka, Cassiano Francisco Weege</creator><creator>Pereira Pinto, Leão</creator><creator>de Souza, Lélia Batista</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20181201</creationdate><title>Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas</title><author>Souza Freitas, Valéria ; dos Santos, Jean Nunes ; de Andrade Santos, Pedro Paulo ; Nonaka, Cassiano Francisco Weege ; Pereira Pinto, Leão ; de Souza, Lélia Batista</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-fced90214f4737351c5bb0981bd74630edbfdd8efc64ff696c80005036fcec303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenoma, Pleomorphic - metabolism</topic><topic>Adenoma, Pleomorphic - pathology</topic><topic>Carcinoma, Adenoid Cystic - metabolism</topic><topic>Carcinoma, Adenoid Cystic - pathology</topic><topic>Head &amp; Neck</topic><topic>Head and Neck Surgery</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosurgery</topic><topic>Otorhinolaryngology</topic><topic>Salivary Gland Neoplasms - metabolism</topic><topic>Salivary Gland Neoplasms - pathology</topic><topic>Salivary Glands, Minor - metabolism</topic><topic>Salivary Glands, Minor - pathology</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Souza Freitas, Valéria</creatorcontrib><creatorcontrib>dos Santos, Jean Nunes</creatorcontrib><creatorcontrib>de Andrade Santos, Pedro Paulo</creatorcontrib><creatorcontrib>Nonaka, Cassiano Francisco Weege</creatorcontrib><creatorcontrib>Pereira Pinto, Leão</creatorcontrib><creatorcontrib>de Souza, Lélia Batista</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European archives of oto-rhino-laryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Souza Freitas, Valéria</au><au>dos Santos, Jean Nunes</au><au>de Andrade Santos, Pedro Paulo</au><au>Nonaka, Cassiano Francisco Weege</au><au>Pereira Pinto, Leão</au><au>de Souza, Lélia Batista</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas</atitle><jtitle>European archives of oto-rhino-laryngology</jtitle><stitle>Eur Arch Otorhinolaryngol</stitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>275</volume><issue>12</issue><spage>3075</spage><epage>3082</epage><pages>3075-3082</pages><issn>0937-4477</issn><eissn>1434-4726</eissn><abstract>Purpose To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands. Methods Twenty cases of pleomorphic adenomas and 20 cases of adenoid cystic carcinomas were evaluated for the immunohistochemical expression of matrix metalloproteinases-2, -7, -9, and -26 and tissue inhibitors-1 and -2 in tumor parenchyma. Results Most pleomorphic adenomas and adenoid cystic carcinomas showed high expression of matrix metalloproteinases and tissue inhibitors, predominantly located in the tumor cells. There was no statistically significant difference in the expression of the metalloproteinases-2 ( p  = 0.359), -7 ( p  = 0.081), and -26 ( p  = 0 553), as well as the tissue inhibitors-1 ( p  = 0.657), and -2 ( p  = 0.248) between the parenchyma of the studied tumors. Only matrix metalloproteinase-9 showed a significant difference in expression between the two tumors, with adenoid cystic carcinoma showing a more intense staining for this gelatinase ( p  = 0.041). Conclusions The expression of the studied metalloproteinases suggests the involvement of these enzymes in the tissue remodeling process in pleomorphic adenomas and adenoid cystic carcinomas, but only MMP-9, significantly expressed in the adenoid cystic carcinomas, appears to be involved in the process of invasiveness and more aggressive behavior of these tumors. Additionally, results point that TIMPs-1 and -2 may have more complex functions besides metalloproteinase inhibition, which may be related to the pathogenesis and biological behavior of salivary gland tumors.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30361787</pmid><doi>10.1007/s00405-018-5176-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0937-4477
ispartof European archives of oto-rhino-laryngology, 2018-12, Vol.275 (12), p.3075-3082
issn 0937-4477
1434-4726
language eng
recordid cdi_proquest_miscellaneous_2126907951
source MEDLINE; SpringerNature Journals
subjects Adenoma, Pleomorphic - metabolism
Adenoma, Pleomorphic - pathology
Carcinoma, Adenoid Cystic - metabolism
Carcinoma, Adenoid Cystic - pathology
Head & Neck
Head and Neck Surgery
Humans
Immunohistochemistry
Matrix Metalloproteinases - metabolism
Medicine
Medicine & Public Health
Neurosurgery
Otorhinolaryngology
Salivary Gland Neoplasms - metabolism
Salivary Gland Neoplasms - pathology
Salivary Glands, Minor - metabolism
Salivary Glands, Minor - pathology
Tissue Inhibitor of Metalloproteinase-1 - metabolism
Tissue Inhibitor of Metalloproteinase-2 - metabolism
title Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A18%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20matrix%20metalloproteinases%20(MMPs-2,%20-7,%20-9,%20and%20-26)%20and%20tissue%20inhibitors%20of%20metalloproteinases%20(TIMPs-1%20and%20-2)%20in%20pleomorphic%20adenomas%20and%20adenoid%20cystic%20carcinomas&rft.jtitle=European%20archives%20of%20oto-rhino-laryngology&rft.au=Souza%20Freitas,%20Val%C3%A9ria&rft.date=2018-12-01&rft.volume=275&rft.issue=12&rft.spage=3075&rft.epage=3082&rft.pages=3075-3082&rft.issn=0937-4477&rft.eissn=1434-4726&rft_id=info:doi/10.1007/s00405-018-5176-0&rft_dat=%3Cproquest_cross%3E2126907951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2126907951&rft_id=info:pmid/30361787&rfr_iscdi=true